Please provide your email address to receive an email when new articles are posted on . Until recently, orthopedic surgeons lacked specialty-specific recommendations for preventing venous ...

Most practicing orthopaedic surgeons currently use a pharmacologic agent as a means of prophylaxis for deep venous thrombosis and pulmonary embolism following total hip arthroplasty, total knee ...

New evidence-based guidelines from the American College of Chest Physicians (ACCP) recommend considering individual patients' risk of thrombosis when deciding for or against the use of preventive ...

Please provide your email address to receive an email when new articles are posted on . A systematic review of randomized studies comparing aspirin with anticoagulation for the prevention of venous ...

Stakeholders concurred that the occurrence of VTE events is a significant public health concern. According to Ralph J. Riello III, PharmD, “It is a problem often that hospitals do not know that they ...

Missed doses of prophylactic anticoagulation account for much of the deep vein thrombosis (DVT) that occurs in surgery and trauma patients, a study showed. Among 202 such patients admitted to a level ...

People who sustain a traumatic brain injury (TBI) are at high risk for developing deep vein thrombosis and pulmonary embolism. But blood-thinning medications started within 72 hours of hospital ...

Venous thromboembolism (VTE) is a major cause of morbidity and mortality in patients with cancer. Primary prevention with pharmacologic agents (or mechanical methods, if anticoagulants are ...

The sponsor submitted a de novo cost analysis using a decision tree model that estimated the cost associated with the geko device compared with no mechanical prophylaxis. The model population was ...

There is no clinically significant difference between warfarin and enoxaparin prophylaxis in terms of efficacy (venographic or clinical events) and safety for hip arthroplasty patients. There is no ...